Active Filter(s):
Details:
Albumedix Recombumin® rHA is an essential component in VLA2001, used in the manufacturing process and final formulation of the vaccine. VLA2001 is produced on Valneva’s established Vero-cell platform, leveraging the manufacturing technology.
Lead Product(s): VLA2001,CpG 1018,Aluminium Hydroxide
Therapeutic Area: Infections and Infectious Diseases Product Name: VLA2001
Highest Development Status: Approved Product Type: Vaccine
Partner/Sponsor/Collaborator: Valneva
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Expanded Collaboration April 14, 2022